𝔖 Bobbio Scriptorium
✦   LIBER   ✦

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

✍ Scribed by Dennis Bourdette; Vijayshree Yadav


Book ID
107545628
Publisher
Springer
Year
2008
Tongue
English
Weight
143 KB
Volume
8
Category
Article
ISSN
1528-4042

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Rituximab in relapsing-remitting multipl
✍ Amit Bar-Or; Peter A. J. Calabresi; Douglas Arnold; Clyde Markowitz; Stuart Shaf πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 171 KB

## Abstract We evaluated the safety, tolerability, pharmacodynamics, and activity of B‐cell depletion with rituximab in patients with relapsing‐remitting multiple sclerosis, receiving two courses of rituximab 6 months apart, and followed for a total of 72 weeks. No serious adverse events were noted